Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 29, 2019 8:59am
85 Views
Post# 29875863

RE:Can anyone explain to me----

RE:Can anyone explain to me----
Impalaman wrote: Why the company Tlt and Mackie would annouce a PP without a set price---What the Hell---I'm having sleepless nights trying to figure it out-----Anybody tackle that.


It is unusual. You'd think they would have a pretty good idea what the capital markets are willing to pay to fill the prospectus. Reminds me of a basketball player testing the free agency market to see what the market will bear. They way they are going about it it gives the impression that they aren't satisfied with the offers so far and are shopping around for something better. The fact that they included 5 year warrants when the trial is only scheduled to last 3 years may indicate a recognition that in order to secure the funds they will have to include some compelling incentives. The maximum discount a company can offer on the Venture for a PP is 25% but I doubt they will have to be so generous. I'm guessing 15% over the average sp for a 2 week period would be more appropriate but if they are able to strike a deal for the full $15 million then who knows if it could be higher.
Bullboard Posts